UBS Reiterates Neutral Rating on Vifor Pharma AG (VIFN:SW) (GNHAY)

April 22, 2020 8:35 AM EDT
Get Alerts VIFN:SW Hot Sheet
Price: $0.00 --0%

Trade Now! 
Join SI Premium – FREE

UBS analyst Laura Sutcliffe reiterated a Neutral rating and CHF150.00 price target on Vifor Pharma AG (VIFN:SW) (OTC: GNHAY).

You May Also Be Interested In

Related Categories

Intl Ratings